Yuliya Yakymiv

4PUBLICATIONS
20CO-AUTHORS
Haematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|May 25, 2026
Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.

|Jun 25, 2025
Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer Syndromes.

Chiara Anna Fiasconaro, Alice Carbone, Silvia Giordano

|Feb 25, 2025
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas.

Liyun Lin, Gabriele Roccuzzo, Yuliya Yakymiv

|Aug 30, 2022
CD39/CD73 dysregulation and adenosine metabolism contribute to T-cell immunosuppression in patients with Sézary syndrome.

Yuliya Yakymiv, Sara Marchisio, Erika Ortolan

Pageof 1

Frequent Collaborators

3 joint publications

Sara Marchisio

3 joint publications

Erika Ortolan

3 joint publications

Ada Funaro

3 joint publications

Gabriele Roccuzzo

2 joint publications

Valentina Pala

2 joint publications

Simone Ribero

1 joint publications

Rebecca Senetta

1 joint publications

Adèle de Masson

1 joint publications

Maxime Battistella

1 joint publications

Emmanuella Guenova

Frequent Collaborators

3 joint publications

Sara Marchisio

3 joint publications

Erika Ortolan

3 joint publications

Ada Funaro

3 joint publications

Gabriele Roccuzzo

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us